Financhill
Back

Inhibrx 10K Form

Sell
49

INBX
Inhibrx

Last Price:
34.96
Seasonality Move:
-13.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INBX News And Ratings

See the #1 stock for the next 7 days that we like better than INBX

INBX Financial Statistics

Sales & Book Value

Annual Sales: $1.8M
Cash Flow: $-60.26M
Price / Cash Flow: 0
Annual Sales: $0.92
Price / Book: 38.13

Profitability

EPS (TTM): -5.12000
Net Income (TTM): $-241.36M
Gross Margin: --
Return on Equity: -544.89%
Return on Assets: -83.9%

Inhibrx Earnings Forecast

Key Inhibrx Financial Ratios

  • The Research & Development expenses have been 10,646.67% of Revenue.
  • The Interest Expense is -13.19% of Operating Income.
  • The Net Earning history of INBX is -13,408.94% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 1 years.

Inhibrx Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: INBX
Website: inhibrx.com

Debt

Debt-to-Equity Ratio: 4.76
Current Ratio: 5.25
Quick Ratio: 4.95

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INBX Technical Analysis vs Fundamental Analysis

Sell
49
Inhibrx (INBX) is a Sell

Is Inhibrx a Buy or a Sell?

  • Inhibrx stock is rated a Sell
    The current Inhibrx [INBX] share price is $35.00. The Score for INBX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.